Panel Discussion: Accelerating Cell Therapy Development Through the Power of Strategic Collaborations
Join BD for an exclusive panel discussion with leading researchers and industry experts to share best practices for implementing new technologies in cell therapy research and development with a focus on how scientists and manufacturers can achieve precision, efficiency and scalability.
This session aims to help researchers, process development teams and manufacturers enhance product insights and optimize analytical workflows to speed up time to market. It will offer valuable insights for developing next-generation therapies and improving manufacturing processes, addressing challenges, and driving significant progress.
Don’t miss this opportunity to connect with industry pioneers, gain practical takeaways, and be part of the conversation shaping the future of cell therapy.
Key discussion topics include:
- Advancing Discovery with Cutting-Edge Tools: The advantage of using high-dimensional spectral and imaging flow cytometry and single-cell multiomics to uncover novel insights about your cell therapy products.
- Standardizing Cytometry for Manufacturing QC: The role of dried down reagents and automation in ensuring consistency, reproducibility and compliance in cell therapy manufacturing QC.
- Building Strategic Partnerships for Success: The importance of collaborating with a global reagent and technology provider to help you streamline your development and meet your scalability needs.
Speakers
Aaron Tyznik
Director, Scientific Affairs
BD Biosciences
Scott Bornheimer
Director
Biomarkers & CDx, Medical &
Scientific Affairs, Medical Affairs
